Gavilyte-N, PEG-3350, Sodium chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solutio...

FDA Drug Recall #D-1113-2019 — Class II — March 19, 2019

Recall Summary

Recall Number D-1113-2019
Classification Class II — Moderate risk
Date Initiated March 19, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm LUPIN SOMERSET
Location Somerset, NJ
Product Type Drugs
Quantity 76422 bottles

Product Description

Gavilyte-N, PEG-3350, Sodium chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solution, Rx only, Manufactured by Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, MD NDC 43386-050-19 UPC 343386050192 a) Lemon Flavor Pack net wt. 2 g UPC 343386200023 b) Orange Flavor Pack net wt. 2 g UPC 343386202027 c) Cherry Flavor Pack net wt. 2 g UPC 3433862034

Reason for Recall

Labeling Not Elsewhere Classified; orange and cherry flavor packets incorrect list "natural lemon flavor" as an ingredient

Distribution Pattern

Nationwide

Lot / Code Information

Lot #: a) S800021, Exp 30-Nov-20; b) S800175, Exp 31-Dec-20; c) S 800401, Exp 28-Feb-21; S800426, Exp 31-Mar-21; S800920, Exp 31-Aug-21.

Other Recalls from LUPIN SOMERSET

Recall # Classification Product Date
D-1245-2019 Class III Morphine Sulfate Extended-Release Tablets, 60 m... Apr 10, 2019
D-1244-2019 Class III Morphine Sulfate Extended-Release Tablets, 30 m... Apr 10, 2019
D-1243-2019 Class III Morphine Sulfate Extended-Release Tablets, 15 m... Apr 10, 2019
D-1247-2019 Class III Morphine Sulfate Extended-Release Tablets, 200 ... Apr 10, 2019
D-1246-2019 Class III Morphine Sulfate Extended-Release Tablets, 100 ... Apr 10, 2019

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.